All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.
Bone damage related to increased bone resorption is a feature of many cancers. Bisphosphonates are drugs that inhibit this process by reducing the number and activity of osteoclasts. They are often used in the treatment of patients with cancer to relieve bone pain, reduce the risk of fractures, and manage hypercalcemia.
Save to your areas of interest